Regeneron Pharmaceuticals, Inc. (0R2M.L)
USD 732.14
(-1.06%)
USD 732.14
(-1.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 13.11 Billion | 12.17 Billion | 16.07 Billion | 8.49 Billion | 7.86 Billion | 6.71 Billion |
| Cost of Revenue | 1.81 Billion | 1.56 Billion | 2.43 Billion | 1.11 Billion | 782.2 Million | 434.1 Million |
| Gross Profit | 11.3 Billion | 10.61 Billion | 13.63 Billion | 7.37 Billion | 7.08 Billion | 6.27 Billion |
| Operating Expenses | 2.81 Billion | 5.61 Billion | 4.68 Billion | 3.8 Billion | 4.87 Billion | 3.74 Billion |
| Selling, General and Administrative Expenses | 2.63 Billion | 2.11 Billion | 1.82 Billion | 1.34 Billion | 1.83 Billion | 1.55 Billion |
| Research and Development Expenses | 4.43 Billion | 3.59 Billion | 2.9 Billion | 2.73 Billion | 3.03 Billion | 2.18 Billion |
| Other Expenses | 184 Million | -89.9 Million | -45.6 Million | -280.4 Million | 219.3 Million | 19.1 Million |
| Cost and Expenses | 9.07 Billion | 7.17 Billion | 7.12 Billion | 4.92 Billion | 5.65 Billion | 4.17 Billion |
| Operating Income | 4.04 Billion | 4.73 Billion | 8.94 Billion | 3.57 Billion | 2.2 Billion | 2.53 Billion |
| Interest Expense | 73 Million | 59.4 Million | 57.3 Million | 56.9 Million | 30.2 Million | 28.2 Million |
| Income Tax Expense | 245.7 Million | 520.4 Million | 1.25 Billion | 297.2 Million | 313.3 Million | 109.1 Million |
| Earnings before Tax | 4.19 Billion | 4.85 Billion | 9.32 Billion | 3.81 Billion | 2.42 Billion | 2.55 Billion |
| Net Income | 3.95 Billion | 4.33 Billion | 8.07 Billion | 3.51 Billion | 2.11 Billion | 2.44 Billion |
| Earnings Per Share Basic | 37.05 | 40.51 | 76.40 | 32.65 | 19.38 | 21.29 |
| Earnings Per Share Diluted | 34.77 | 38.22 | 71.97 | 30.52 | 18.46 | 21.29 |
| Weighted Average Shares Outstanding | 106.7 Million | 107.1 Million | 105.7 Million | 107.6 Million | 109.2 Million | 114.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 113.7 Million | 113.5 Million | 112.2 Million | 115.1 Million | 114.6 Million | 114.8 Million |
| Gross Margin | 0.86 | 0.87 | 0.85 | 0.87 | 0.90 | 0.94 |
| EBIT Margin | 0.35 | 0.42 | 0.58 | 0.46 | 0.28 | 0.38 |
| Profit Margin | 0.30 | 0.36 | 0.50 | 0.41 | 0.27 | 0.36 |
| EBITDA | 4.65 Billion | 5.33 Billion | 9.28 Billion | 3.9 Billion | 2.42 Billion | 2.68 Billion |
| Earnings Before Tax Margin | 0.31 | 0.39 | 0.56 | 0.42 | 0.28 | 0.38 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 3.72 Billion | 3.54 Billion | 3.14 Billion | 13.11 Billion | 3.43 Billion | 3.36 Billion |
| Cost of Revenue | 228.8 Million | 600.9 Million | 547.9 Million | 1.81 Billion | 517 Million | 211.9 Million |
| Gross Profit | 3.49 Billion | 2.94 Billion | 2.59 Billion | 11.3 Billion | 2.91 Billion | 3.15 Billion |
| Operating Expenses | 1.98 Billion | 1.85 Billion | 1.83 Billion | 7.06 Billion | 1.91 Billion | 1.71 Billion |
| Selling, General and Administrative Expenses | 714.4 Million | 758.8 Million | 689 Million | - | 737.7 Million | 640.5 Million |
| Research and Development Expenses | 1.27 Billion | 1.07 Billion | 1.13 Billion | - | 1.17 Billion | 1.07 Billion |
| Other Expenses | -8 Million | -14.6 Million | -15.3 Million | -20 Million | -900 Thousand | -15.8 Million |
| Cost and Expenses | 2.21 Billion | 2.45 Billion | 2.38 Billion | 8.88 Billion | 2.43 Billion | 1.92 Billion |
| Operating Income | 1.17 Billion | 1.09 Billion | 758.5 Million | 4.04 Billion | 972.9 Million | 1.11 Billion |
| Interest Expense | -13.8 Million | 14.8 Million | 16.1 Million | 73 Million | 18.3 Million | -17.8 Million |
| Income Tax Expense | 152.4 Million | 195.8 Million | -21.3 Million | 245.7 Million | -12 Million | 103 Million |
| Earnings before Tax | 1.49 Billion | 1.62 Billion | 700.7 Million | 4.19 Billion | 1.14 Billion | 1.11 Billion |
| Net Income | 1.34 Billion | 1.43 Billion | 722 Million | 3.95 Billion | 1.15 Billion | 1 Billion |
| Earnings Per Share Basic | 12.40 | 13.25 | 6.70 | - | 10.88 | 9.48 |
| Earnings Per Share Diluted | 11.54 | 12.41 | 6.27 | - | 10.19 | 8.89 |
| Weighted Average Shares Outstanding | 108.1 Million | 108.1 Million | 107.8 Million | 106.7 Million | 106.6 Million | 106.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 116.2 Million | 115.4 Million | 115.1 Million | 113.7 Million | 113.8 Million | 113.4 Million |
| Gross Margin | 0.94 | 0.83 | 0.83 | 0.86 | 0.85 | 0.94 |
| EBIT Margin | 0.32 | 0.34 | 0.28 | - | 0.37 | 0.33 |
| Profit Margin | 0.36 | 0.40 | 0.23 | 0.30 | 0.34 | 0.30 |
| EBITDA | 1.17 Billion | 1.21 Billion | 872.6 Million | - | 1.26 Billion | 1.11 Billion |
| Earnings Before Tax Margin | 0.32 | 0.31 | 0.24 | 0.31 | 0.28 | 0.33 |
VQSSF
JOUT
MCB
KTB-R
FULTP
PEG